KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Pension (2016 - 2025)

Historic Pension for Astrazeneca (AZN) over the last 16 years, with Q4 2025 value amounting to -$1.1 billion.

  • Astrazeneca's Pension rose 1691.73% to -$1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.1 billion, marking a year-over-year increase of 1691.73%. This contributed to the annual value of -$1.1 billion for FY2025, which is 1691.73% up from last year.
  • According to the latest figures from Q4 2025, Astrazeneca's Pension is -$1.1 billion, which was up 1691.73% from -$1.3 billion recorded in Q3 2025.
  • In the past 5 years, Astrazeneca's Pension ranged from a high of $2.5 billion in Q4 2021 and a low of -$2.5 billion during Q1 2021
  • In the last 5 years, Astrazeneca's Pension had a median value of -$1.3 billion in 2024 and averaged -$1.0 billion.
  • Per our database at Business Quant, Astrazeneca's Pension skyrocketed by 19991.41% in 2021 and then crashed by 18750.0% in 2024.
  • Over the past 5 years, Astrazeneca's Pension (Quarter) stood at $2.5 billion in 2021, then crashed by 52.4% to $1.2 billion in 2022, then skyrocketed by 30.14% to $1.5 billion in 2023, then tumbled by 187.5% to -$1.3 billion in 2024, then grew by 16.92% to -$1.1 billion in 2025.
  • Its last three reported values are -$1.1 billion in Q4 2025, -$1.3 billion for Q3 2025, and -$1.4 billion during Q2 2025.